INSP
Inspire Medical Systems, Inc.Company Information
- Company Name
- Inspire Medical Systems, Inc.
- CIK
- CIK0001609550
- Category
- Large accelerated filer
- Ticker: Exchange
- INSP: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- INSP
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-04-07
- Last sale
- 2026-08-07
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 19,313
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 35,855,108
- Shares outstanding
- 28,835,058
- Ownership
- 124.35%
Earnings Market Reaction
- Filing date
- 2026-08-03
- Price on filing date
- —
- 1-month reaction
- 17.66%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 128 | 99 | 105 | 113 | 107 | 54 | 150 | 148 | 188 | 175 | 186 | 330 | ||||||
| Short Term Investments | 193 | 185 | 203 | 210 | 194 | 315 | 295 | 263 | 252 | 266 | 275 | 134 | ||||||
| Accounts Receivable Net Current | 103 | 105 | 120 | 108 | 138 | 93 | 93 | 90 | 80 | 72 | 90 | 71 | ||||||
| Inventory Net | 170 | 166 | 145 | 142 | 122 | 100 | 80 | 67 | 59 | 49 | 34 | 26 | ||||||
| Prepaid Expense Current | 14 | 12 | 10 | 14 | 13 | 10 | 12 | 14 | 29 | 10 | 10 | 8 | ||||||
| Assets Current | 609 | 567 | 584 | 586 | 573 | 572 | 631 | 583 | 607 | 572 | 594 | 570 | ||||||
| Long Term Investments | 94 | 116 | 96 | 88 | 110 | 45 | 71 | 113 | 26 | 28 | 9 | 3 | ||||||
| Property Plant And Equipment Net | 104 | 101 | 98 | 92 | 85 | 77 | 72 | 67 | 62 | 52 | 40 | 32 | ||||||
| Operating Lease Right Of Use Asset | 23 | 23 | 24 | 24 | 25 | 25 | 23 | 22 | 22 | 22 | 23 | 23 | ||||||
| Deferred Income Tax Assets Net | 78 | 88 | 89 | - | - | - | 0 | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 18 | 17 | 17 | 17 | 9 | 12 | 11 | 11 | 11 | 11 | 11 | 12 | ||||||
| Assets | 926 | 911 | 907 | 808 | 802 | 731 | 808 | 796 | 728 | 686 | 677 | 639 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Trade Current | 27 | 42 | 37 | 59 | 53 | 29 | 39 | 35 | 34 | 44 | 39 | 40 | ||||||
| Accrued Liabilities Current | 44 | 48 | 59 | 52 | 40 | 34 | 50 | 39 | 32 | 28 | 39 | 30 | ||||||
| Liabilities Current | 71 | 89 | 96 | 111 | 93 | 63 | 89 | 74 | 66 | 72 | 78 | 70 | ||||||
| Operating Lease Liability Noncurrent | 29 | 30 | 30 | 30 | 31 | 31 | 30 | 25 | 25 | 25 | 25 | 25 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | ||||||
| Liabilities | 100 | 119 | 126 | 141 | 124 | 95 | 119 | 100 | 90 | 97 | 104 | 95 | ||||||
Stockholders Equity Including Portion Attributable To Noncontrolling Interest | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 984 | 950 | 927 | 948 | 970 | 924 | 981 | 1,022 | 984 | 944 | 917 | 904 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -1 | -0 | 0 | 1 | 0 | 0 | 1 | 2 | -0 | 0 | 1 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -157 | -158 | -146 | -283 | -293 | -289 | -292 | -327 | -346 | -355 | -345 | -360 | ||||||
| Stockholders Equity | 826 | 792 | 781 | 666 | 678 | 636 | 690 | 697 | 638 | 589 | 573 | 544 | ||||||
| Liabilities And Stockholders Equity | 926 | 911 | 907 | 808 | 802 | 731 | 808 | 796 | 728 | 686 | 677 | 639 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 2 | 1 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 29 | 29 | 29 | 29 | 30 | 29 | 30 | 30 | 30 | 30 | 30 | 29 | ||||||
| Shares Outstanding | 29 | 29 | 29 | 29 | 30 | 29 | 30 | 30 | 30 | 30 | 30 | 29 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialInspire Medical Systems, Inc. (INSP) — SEC Financial Statements & Analysis
Inspire Medical Systems, Inc. (INSP) is a surgical & medical instruments & apparatus company, incorporated in DE. Inspire Medical Systems, Inc. trades on NYSE as: INSP. Inspire Medical Systems, Inc. (INSP)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-03. Based on that filing, Inspire Medical Systems, Inc. carries a market cap of $1.29B, a P/E ratio of 9.53x, a P/B ratio of 1.56x, a P/S ratio of 1.43x, an enterprise value of $1.16B, and an EV/EBITDA multiple of 16.24x. On profitability, it posts a gross margin of 86.13%, an operating margin of 6.02%, a net margin of 15.03%, a Return on Equity (ROE) of 17.96%, a Return on Assets (ROA) of 15.63%, and a Return on Invested Capital (ROIC) of 8.30%. Per share, it reports EPS of $4.68, diluted EPS of $4.67, free cash flow per share of $4.06, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 4.35% year-over-year, net income growth of 154.22% year-over-year, and EPS growth of 160.14% year-over-year. On the balance sheet, it maintains a current ratio of 8.55x, a quick ratio of 5.96x, working capital of $537.49M, a debt-to-equity ratio of 0.12x, a debt ratio of 0.11, an interest coverage ratio of 406.94x, free cash flow of $117.09M (TTM), and net debt of $-127.76M. Figures sourced from SEC EDGAR.
- Market Cap
- $1.29B
- P/E TTM
- 9.53x
- EPS TTM
- $4.68
- P/B TTM
- 1.56x
- ROE TTM
- 17.96%
- ROA TTM
- 15.63%
- Debt To Equity
- 0.12x
- Free Cash Flow TTM
- $117.09M
- Net Revenue TTM Growth 1Y
- 4.35%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Inspire Medical Systems, Inc. in?
Inspire Medical Systems, Inc. (INSP) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does INSP trade on?
Inspire Medical Systems, Inc. (INSP) trades on the NYSE.
Where is Inspire Medical Systems, Inc. incorporated?
Inspire Medical Systems, Inc. is incorporated in DE.
When was Inspire Medical Systems, Inc. (INSP)'s most recent SEC filing?
Inspire Medical Systems, Inc. (INSP)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-03.
What is INSP's market cap?
Inspire Medical Systems, Inc. (INSP) has a market capitalization of $1.29B as of 2026-06-30.
What is INSP's P/E ratio?
Inspire Medical Systems, Inc. (INSP)'s trailing twelve month P/E ratio is 9.53x as of 2026-06-30.
What is INSP's EPS (earnings per share)?
Inspire Medical Systems, Inc. (INSP)'s trailing twelve month EPS is $4.68 as of 2026-06-30.
What is INSP's ROE (return on equity)?
Inspire Medical Systems, Inc. (INSP)'s trailing twelve month Return on Equity (ROE) is 17.96% as of 2026-06-30.
What is INSP's ROA (return on assets)?
Inspire Medical Systems, Inc. (INSP)'s trailing twelve month Return on Assets (ROA) is 15.63% as of 2026-06-30.
What is INSP's ROIC (return on invested capital)?
Inspire Medical Systems, Inc. (INSP)'s trailing twelve month Return on Invested Capital (ROIC) is 8.30% as of 2026-06-30.
What is INSP's EV/EBITDA?
Inspire Medical Systems, Inc. (INSP)'s trailing twelve month EV/EBITDA is 16.24x as of 2026-06-30.